Rx Cost-Saving Potential In Medicare Not Yet Demonstrated, CBO Says
Executive Summary
Congressional Budget Office cost estimates for Medicare prescription drug proposals will continue to leave out any estimate of cost savings from expanded use of pharmaceuticals, CBO Director Douglas Holtz-Eakin suggested during an April 9 House Ways & Means Committee hearing
You may also be interested in...
Does Drug Spending Pay for Itself? Researchers Look to Private Plans
Forthcoming studies could move forward the debate over the impact of drugs on the overall cost of health care
Does Drug Spending Pay for Itself? Researchers Look to Private Plans
Forthcoming studies could move forward the debate over the impact of drugs on the overall cost of health care
Senate Medicare Vote Suggests $400 Bil. Rx Benefit Is Winning Formula
The magic number in the Medicare prescription drug coverage debate appears to be $400 bil. over 10 years